Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (341-350 of 437) with videos related to

Pageof 44
Sort By:
Leukemia|November 17, 2021
Publisher Correction: Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Pediatric Blood & Cancer|July 4, 2020
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioningKatharina Wustrau, Johann Greil, Karl-Walter Sykora, et al.
Journal of Clinical Immunology|September 29, 2021
Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHDDanielle E Arnold, Rofida Nofal, Connor Wakefield, et al.
Leukemia|March 5, 2020
Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylaseCarol K Wada, Robin R Frey, Zhiqin Ji, et al.
Journal of Clinical Immunology|February 13, 2014
Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantationDhaarini Murugan, Michael H Albert, Jörg Langemeier, et al.
Leukemia|December 13, 2019
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignanciesDarren C Phillips, Sha Jin, Gareth P Gregory, et al.
Journal of Clinical Immunology|January 5, 2019
Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair DisordersDavid Buchbinder, Fabian Hauck, Michael H Albert, et al.
Blood|February 23, 2010
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment optionsMichael H Albert, Tanja C Bittner, Shigeaki Nonoyama, et al.
Pageof 44

Showing results (341-350 of 437) with videos related to

Sort By:
Pageof 44
Leukemia|November 17, 2021
Publisher Correction: Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Pediatric Blood & Cancer|July 4, 2020
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioningKatharina Wustrau, Johann Greil, Karl-Walter Sykora, et al.
Journal of Clinical Immunology|September 29, 2021
Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHDDanielle E Arnold, Rofida Nofal, Connor Wakefield, et al.
Leukemia|March 5, 2020
Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylaseCarol K Wada, Robin R Frey, Zhiqin Ji, et al.
Journal of Clinical Immunology|February 13, 2014
Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantationDhaarini Murugan, Michael H Albert, Jörg Langemeier, et al.
Leukemia|December 13, 2019
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignanciesDarren C Phillips, Sha Jin, Gareth P Gregory, et al.
Journal of Clinical Immunology|January 5, 2019
Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair DisordersDavid Buchbinder, Fabian Hauck, Michael H Albert, et al.
Blood|February 23, 2010
X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment optionsMichael H Albert, Tanja C Bittner, Shigeaki Nonoyama, et al.
Pageof 44